Investor Presentation Full Year 2017

Investor Presentation Novo Nordisk strategic foundation STRATEGIC PRIORITIES Strengthen leadership in DIABETES CARE CORE CAPABILITIES Engineering, formulating, developing and delivering protein-based treatments Deep disease understanding Strengthen leadership in OBESITY CARE Pursue leadership in HAEMOPHILIA Strengthen leadership in GROWTH DISORDERS Expand into other SERIOUS CHRONIC DISEASES changing diabetes Novo Nordisk Way Efficient large-scale production of proteins Full year 2017 Slide 24 Global commercial reach and leader in chronic disease care Driving change to defeat diabetes and other serious chronic conditions novo nordisk

View entire presentation